Related Experiment Video

Updated: Jun 18, 2025

A Minimally Invasive Method for Intratracheal Instillation of Drugs in Neonatal Rodents to Treat Lung Disease
04:21

A Minimally Invasive Method for Intratracheal Instillation of Drugs in Neonatal Rodents to Treat Lung Disease

Published on: August 4, 2021

5.8K

Innovations in Childhood Interstitial and Diffuse Lung Disease

Alicia Casey1, Elizabeth K Fiorino2, Jennifer Wambach3

  • 1Department of Pediatrics, Division of Pulmonary Medicine, Harvard Medical School, Boston Children's Hospital, Boston, MA 02115, USA.

Clinics in Chest Medicine
|July 28, 2024
PubMed

Insights

Children's interstitial and diffuse lung diseases (chILDs) are diverse lung disorders in children. Innovations in diagnosis and care, including multidisciplinary teams and research networks, are improving outcomes for these complex conditions.

Area of Science:

  • Pediatric Pulmonology
  • Rare Diseases
  • Medical Diagnostics

Background:

  • Children's interstitial and diffuse lung diseases (chILDs) represent a heterogeneous group of rare pulmonary conditions affecting infants and children.
  • These disorders manifest with respiratory symptoms and diffuse lung abnormalities on imaging, leading to substantial healthcare utilization, morbidity, and mortality.

Purpose of the Study:

  • To review past and current innovations in the diagnosis and clinical management of chILDs.
  • To highlight advancements in multidisciplinary care and collaborative research efforts.

Main Methods:

  • Literature review of diagnostic and clinical care innovations for chILDs.
  • Analysis of the impact of multidisciplinary care and patient research networks.

Main Results:

  • Significant improvements in chILD patient care have been achieved through collaborative efforts.
  • Multidisciplinary care models and established research networks have enhanced diagnosis and management strategies.

Conclusions:

  • Multicenter collaboration and patient research networks are crucial for advancing the care of children with chILDs.
  • Ongoing innovations in diagnosis and clinical practice are vital for improving outcomes in these complex pediatric lung diseases.

Keywords:
Childhood interstitial lung diseaseNeuroendocrine hyperplasia of infancyPediatric pulmonologyPulmonary fibrosisSurfactant dysfunction

More Related Videos

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus06:15

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus

Published on: March 6, 2019

49.8K
Direct Tracheal Instillation of Solutes into Mouse Lung04:50

Direct Tracheal Instillation of Solutes into Mouse Lung

Published on: August 29, 2010

29.2K

Related Concept Videos

Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
1.5K
Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
59.0K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
217
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
809
Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
246
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K